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Abstract
Background:  Microarray technology has been used extensively over the past 10 years for
assessing gene expression, and has facilitated precise genetic profiling of everything from tumors to
small molecule drugs. By contrast, arraying cell membranes in a manner which preserves their
ability to mediate biochemical processes has been considerably more difficult.
Results: In this article, we describe a novel technology for generating cell membrane microarrays
for performing high throughput biology. Our robotically-arrayed supported membranes are
physiologically fluid, a critical property which differentiates this technology from other previous
membrane systems and makes it useful for studying cellular processes on an industrialized scale.
Membrane array elements consist of a solid substrate, above which resides a fluid supported lipid
bilayer containing biologically-active molecules of interest. Incorporation of transmembrane
proteins into the arrayed membranes enables the study of ligand/receptor binding, as well as
interactions with live intact cells. The fluidity of these molecules in the planar lipid bilayer facilitates
dimerization and other higher order interactions necessary for biological signaling events. In order
to demonstrate the utility of our fluid membrane array technology to ligand/receptor studies, we
investigated the multivalent binding of the cholera toxin B-subunit (CTB) to the membrane
ganglioside GM1. We have also displayed a number of bona fide drug targets, including bacterial
endotoxin (also referred to as lipopolysaccharide (LPS)) and membrane proteins important in T
cell activation.
Conclusion: We have demonstrated the applicability of our fluid cell membrane array technology
to both academic research applications and industrial drug discovery. Our technology facilitates the
study of ligand/receptor interactions and cell-cell signaling, providing rich qualitative and
quantitative information.
Background
DNA and protein microarrays have enabled the measure-
ment of gene expression and biomarkers on an unprece-
dented scale, and have greatly affected fields ranging from
oncology to medical diagnostics. However, assaying bio-
logical events occurring on cell membranes, including
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signal transduction and intercellular communication, has
proven to be considerably more difficult to industrialize
in microarray format. Basic methods for reconstituting
membrane proteins into phospholipid vesicles were
developed quite a number of years ago [1], facilitating
fundamental discoveries in such diverse cellular processes
as metabolism, solute transport, protein trafficking, and
signal transduction. In subsequent years, it was demon-
strated that planar phospholipid bilayers could be gener-
ated simply by fusing these vesicles to various solid
substrates (e.g. glass [2] and quartz [3]), generating "sup-
ported membranes" which have lateral fluidity. The char-
acteristic fluidity, uniformity of lipid/protein orientation,
and planarity make these supported membranes ideal for
studying most membrane components, including recep-
tors, transporters, channels, and adhesive factors. Alterna-
tively, planar lipid bilayers can be deposited on surfaces
derivatized with various polymeric films [4-6]. Regardless
of how the planar membrane interacts with the solid sup-
port, display of these lipid bilayers represents a powerful
way of developing technologies ranging from biosensors
[4,7] to platforms for the study of ion channel electro-
physiology [8]. Given the increasing complexity of current
basic research experiments and industrial drug discovery
schemes, the ability to pattern arrays of lipid bilayers has
become almost essential for performing multiplexed, high
information-content assays. To address this need, there
have been a number of methods developed over the past
few years to pattern arrays of lipid bilayers on solid sup-
ports for purposes of studying the biology of membranes
and their component lipids and proteins [9-12]. While
these unique approaches all generate patterns of lipid
bilayers on solid supports, they vary greatly in a number
of important ways, including the manner of lipid bilayer
display (e.g. supported above or directly associated with a
polymer linked to the solid support) and the means of
generating the membrane pattern (e.g. lithographic mod-
ification of the solid support to allow selective deposition
of membranes [9,10,12,13] or modification of the planar
bilayer following deposition [11]).
We have recently developed a technology for industrializ-
ing physiologically fluid supported membrane microar-
rays relying upon the discovery that fused silica, normally
a compatible substrate for supported lipid bilayers, can
readily be made membrane-incompatible through vari-
ous lithographic procedures [9,13]. This development led
to the realization that fluid cell membranes could be iso-
lated in independently-addressable corrals on a silicon
chip through lithographic patterning. In essence, microar-
rays consisting of spatially-indexed corrals of supported
lipid bilayers can be generated at very high density (Figure
1) [14]. Membrane corrals are regions of a solid substrate,
in this case fused silica, which are compatible with lipid
bilayer deposition and are isolated from each other by
membrane-barriers composed of chrome. In this manner,
cell membranes are supported on a silicon chip with an
aqueous interface between the membrane and solid sup-
port, as well as a bulk aqueous phase above the mem-
brane [9,13,14]. The isolated membranes in each corral of
the array are physiologically fluid as confirmed by fluores-
cence recovery after photobleaching (FRAP). In this tech-
nique, excitation light shadows a small region of the
corral, photobleaching the fluorescent molecules in that
area. Following this excitation step, the photobleached
region of the corral is examined for a recovery of fluores-
cence which is dependent upon the ability of fluorescent
lipids in the surrounding membrane to diffuse into the
photobleached area. The extent of membrane fluidity
determines the rate at which these fluorescent molecules
diffuse into the photobleached area and diminish the
shadow formed by the excitation step. Another technique
used to measure the fluidity of supported lipid bilayers is
the lateral migration of charged lipids in the presence of
an electric field [9,13,14]. Given their aqueous surround-
ings, both upper and lower bilayers of the membrane
exhibit a physiological level of fluidity. The fluidity of our
supported lipid bilayer arrays permits interactions among
membrane components (e.g. oligomerization of cell sur-
face receptors) on a physiological time scale, a phenome-
non thought to underlie numerous signal transduction
pathways. This report demonstrates that the individually-
corralled lipid bilayers can faithfully mimic the structural
and functional characteristics of in vivo cell membranes,
making them valuable for the study of biological proc-
esses ranging from simple ligand/receptor interactions to
complex cell-cell signaling.
As mentioned previously, fluidity is a critical property of
biological membranes in vivo. According to biophysical
models of membrane fluidity, there is a logarithmic
dependence of the diffusion coefficient of a given mole-
cule (e.g. a membrane protein) on its radius, a phenome-
non enabling large proteins embedded in the membrane
to diffuse nearly as rapidly as lipid molecules [15]. The
fluidity dynamics are completely different for membranes
interacting directly with solid substrates, where friction
greatly attenuates the diffusion of larger molecules (e.g.
proteins) in comparison to lipids [15]. The characteristic
fluidity of supported membranes depends entirely upon
the manner in which the lipid bilayer is prepared and the
type of solid substrate supporting the membrane. In order
to retain such a high level of fluidity, these membranes
cannot be exposed to an air-water interface. Integrated
membrane technologies, in which lipid bilayers are
deposited on a self-assembled chemical monolayer coat-
ing the solid substrate instead of directly on the substrate
itself, have sought to eliminate this drawback. However,
the increased convenience of coating the substrate with a
chemical monolayer is offset by the observation thatBMC Biotechnology 2005, 5:18 http://www.biomedcentral.com/1472-6750/5/18
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integrated membranes have considerably reduced fluidity
(approximately 40% less) in comparison to supported
lipid bilayers deposited directly on bare glass [6]. Conse-
quently, the supported membranes described in this study
display a level of fluidity more characteristic of the in vivo
environment, a property likely to be critical for numerous
cell biological events.
Fluid membrane protein arrays are thus a powerful tech-
nology for displaying lipid bilayers which facilitates the
study of cell surface processes. Planar synthetic mem-
branes and their molecular components are readily dis-
played in a fluid and functional state characteristic of the
in vivo environment. While the basic principles of fluid
bilayer arrays were invented in academia [9,13], we have
industrialized the technology to a level suitable for high
throughput drug screening. By combining lipid biochem-
istry with semiconductor microfabrication and robotic
handling, membranes are arrayed at high density in dis-
crete corrals on a silicon chip. In order to complement the
membrane array, we have also developed methods for
efficiently expressing, purifying, and displaying the vast
majority of membrane proteins in the genome. Taken
together, the membrane array and membrane protein dis-
play technologies enable the study of biological processes
occurring on cell membranes. In this article, we report the
validation of our membrane array technology for studies
pertaining to ligand/receptor binding and live cell-based
assays. We initially characterized our supported lipid
bilayers by displaying glycolipid molecules found in
mammalian (ganglioside GM1) and bacterial (LPS) cells.
We have chosen to study the interaction between CTB and
the membrane ganglioside GM1. Cholera toxin, naturally
secreted by the bacterium Vibrio cholerae, is thought to
exist as a hexamer consisting of two subunits in an AB5
configuration. The pentameric CTB subunit is thought to
bind up to five GM1gangliosides in a cooperative fashion
[16,17]. This multivalent interaction likely requires mem-
brane fluidity for proper stoichiometric assembly of the
ligand/receptor complex. Additionally, we demonstrate
the successful display of various other membrane compo-
nents, including LPS from Gram-negative bacteria and the
mammalian proteins ICAM-1 and I-Ek, molecules which
are important drug targets for treating diseases ranging
from septic shock in the case of the former to autoimmu-
nity in the case of the latter. Gram-negative bacteria dis-
play LPS in the outer membrane of their cell wall. Also
referred to as endotoxin, LPS consists of two distinct
regions: a hydrophilic polysaccharide moiety and the
highly conserved hydrophobic toxin lipid A [18,19]. As
Schematic diagram of cell membrane arrays for drug discovery Figure 1
Schematic diagram of cell membrane arrays for drug discovery. The 64 250-µm × 250-µm corrals are separated by 
750 µm of chrome which prevents contamination of supported membranes from one corral to another. Each corral contains a 
supported lipid bilayer membrane which displays different molecules or different concentrations of the same molecule. The 
array elements are subsequently exposed to ligands or live cells, allowing for observation of differences in binding or cell bio-
logical events among the corrals. Each array resides in a single well of a 96-well plate, facilitating multiplexed assays.BMC Biotechnology 2005, 5:18 http://www.biomedcentral.com/1472-6750/5/18
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LPS is present only in bacterial membranes, it has been a
target of continual interest to drug discovery programs
aimed at developing more efficacious antibiotics. Our
studies examining T cell adhesion and activation on mem-
brane protein arrays displaying immunological proteins
demonstrates the utility of our platform for biological
assays. In these T cell experiments, we have displayed pro-
teins present on antigen presenting cells which are critical
to generating an immunological response: the adhesion
protein ICAM-1 and the class II dimeric antigen-presenta-
tion molecule I-Ek. The ability to study complex multiva-
lent ligand/receptor interactions and the engagement of
live cells with our supported lipid bilayers could aid not
only industrial drug screening against membrane targets,
but also basic research studies in academia.
Results
Arraying high quality supported membranes
We sought to characterize the quality and precision of our
fluid membrane arraying capabilities for industrial pro-
duction. The CTB/GM1 interaction afforded a system to
study our supported lipid bilayers, as its pentavalent struc-
ture is likely to require a high degree of membrane fluidity
for efficient complex formation. As depicted in Figure 2A,
membranes containing unique lipid compositions (red-
or green-fluorescent dopant lipids in this case) were
arrayed at very high density in a manner which prevents
mixing of contents from corral to corral. Moreover, the
arrayed membranes were of high quality in terms of their
physiological level of fluidity, as determined by FRAP
measurements (Figure 2B). In order to demonstrate the
precision of arraying membranes of varying compositions
into specific corrals of an array, we used a pre-written pro-
gram (8 × 8 arrow pattern with 8 samples) to deposit 8 dif-
ferent concentrations of ganglioside GM1 on a chip in a
manner so as to generate an arrow-shaped pattern (Figure
3A). GM1 was detected using fluorescence microscopy fol-
lowing an incubation with fluorescently-labeled CTB
(red), a method we have previously used to investigate
this ligand/receptor pair [14].
High information-content binding of CTB to GM1 arrayed 
on supported membranes
Given the CTB/GM1 binding illustrated in Figure 3A, we
next wished to quantify this ligand/receptor interaction.
Figure 3B depicts a binding experiment performed using
eight 8 × 8 (64 corral) supported membrane arrays dis-
playing varying concentrations of GM1. We used 8 differ-
ent concentrations of GM1 (0.00, 0.02, 0.05, 0.10, 0.18,
0.25, 0.35 and 0.50 mol percent) and 8 different concen-
trations of CTB (0, 5, 10, 20, 30, 50, 100, and 300 nM).
Hence, we performed a ligand binding experiment using
8 replicates for each concentration of CTB applied so as to
obtain highly quantitative and information-rich binding
data with very little reagent material required. The fluid
membranes were arrayed using a pre-written program
consisting of an 8 × 8 standard loop with 8 samples. As in
the case of the membranes in Figure 2, fluidity was con-
firmed using the FRAP technique. Figure 3B is a contour
plot of the quantitation of the CTB/GM1 data, indicating
the expected specific and saturable binding of the ligand
to its receptor.
Incorporation of diverse membrane components into 
supported fluid lipid bilayers and live cell assays
In order to further validate our system for industrial drug
discovery and basic research applications, we have puri-
fied and displayed important molecules mediating micro-
bial pathogenesis (LPS) and various immunological
disorders (ICAM-1 and I-Ek). Lipid A, the principal endo-
toxic moiety of LPS, was displayed in lipid bilayers and
detected specifically by the anti-lipid A antibody (A6),
yielding an approximately 4-fold increase in immunore-
activity compared with membranes devoid of the endo-
toxin (data not shown). We next sought to extend our
technology for assaying membrane biology important to
the immune system. The ectodomains of ICAM-1 (an
adhesion molecule) and I-Ek  (an antigen-presentation
molecule) were over-expressed in mammalian cells, puri-
fied, and displayed in supported lipid bilayers through
glycosylphosphatidylinositol (GPI) tethering (data not
shown). Given that these two proteins are particularly
important in mediating the adhesion and activation of T
cells on antigen-presenting cells, we examined these pro-
teins for their ability to capture a transgenic murine T cell
line [20] specific for the pigeon cytochrome c (PCC) anti-
gen. Figure 4A illustrates that surfaces displaying either
ICAM-1 or I-Ek-complexed to PCC as GPI-linked proteins
mediate specific adhesion of T cells when displayed either
alone or in combination, while membranes devoid of
these proteins confer almost no adhesion. Moreover, in
order to mimic a potential therapeutic intervention, we
show that monoclonal antibodies specific for either
ICAM-1 or I-Ek nearly abolish T cell adhesion, while hav-
ing little effect on the low level of non-specific adhesion
to membranes devoid of protein (Figure 4A). In addition
to measuring adhesion, the physiological level of fluidity
of our supported membranes makes them ideal for assay-
ing the full T cell activation process. Following adhesion
of T cells to antigen-presenting cells, there is a dramatic
relocalization of signaling molecules at the cell-cell inter-
face known as the "immunological synapse," which is
thought to be the most proximal marker of antigen-
dependent T cell activation [21]. Upon initial encounter
of the PCC-specific murine T cells with a membrane dis-
playing fluorescently-labeled ICAM-1 and I-Ek complexed
to PCC peptide, T cells adhere and form an immature
"synapse" characterized by ICAM-1 localized centrally
and I-Ek at the periphery (data not shown). During the
next 30 minutes of T cell engagement, however, thisBMC Biotechnology 2005, 5:18 http://www.biomedcentral.com/1472-6750/5/18
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Independently addressable cell membrane arrays Figure 2
Independently addressable cell membrane arrays. (A) An 8 × 8 64-corral supported membrane array containing differ-
ent molecules (1 mol % NBD-PG or 1 mol % Texas Red DHPE in egg PC) in an alternating pattern was arrayed robotically in a 
manner which prevents mixing of contents from corral to corral. (B) Photobleaching a region of membrane containing 1 mol % 
NBD-PG in egg PC is followed by a recovery.
A
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A single-pass high information-content binding curve of the CTB/GM1 interaction Figure 3
A single-pass high information-content binding curve of the CTB/GM1 interaction. (A) 8 different concentrations of 
ganglioside GM1 (0.00, 0.02, 0.05, 0.10, 0.18, 0.25, 0.35 and 0.50 mol %) are microarrayed in the pattern of an arrow. The chips 
were then exposed to a fluorescently-labeled CTB, revealing the variation in GM1 concentration. (B) This experiment was per-
formed on 8 different supported membrane chips. Using the microarrayer, the eight 8 × 8 chips were prepared with the same 
distribution of ganglioside GM1. They were subsequently exposed to different concentrations of fluorescently-labeled CTB. 
The arrays were imaged microscopically and fluorescence was quantitated using Adobe Photoshop.
A
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Live cell assays for academic research and industrial drug discovery Figure 4
Live cell assays for academic research and industrial drug discovery. (A) Control membranes (devoid of protein) or 
membranes reconstituted with either ICAM-1 or I-Ek-complexed to PCC peptide alone or together were incubated with 
murine T cells specific for PCC in the presence or absence of specific antibodies to either protein. Adhered cells were counted 
under the microscope and averaged from different corrals. (B) Murine T cells specific for PCC were incubated with supported 
lipid bilayers displaying fluorescently-labeled ICAM-1 and I-Ek – complexed to wild-type PCC, a mutated PCC*, or no peptide, 
and were subsequently assayed for the intensity of clustered I-Ek at the center of synapses. Values represent means ± SEM from 
at least 3 independent determinations.
A
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"synaptic" pattern changes dynamically, as the peptide-
loaded I-Ek migrates centrally and ICAM-1 adopts a more
peripheral localization (data not shown). In addition to
measuring "immunological synapse" formation qualita-
tively as has been previously demonstrated [21], we can
also obtain quantitative information about this marker of
T cell activation by measuring the clustering of cell surface
molecules. As presented in Figure 4B, we have quantified
the intensity of clustered I-Ek to measure the strength of
"synapse" formation and, hence, T cell activation. As a
control for quantitative measurement, we have compared
the strength of "synapse" formation in the presence of I-Ek
complexed to a wild-type PCC peptide to that complexed
to either no peptide or a mutated PCC* peptide which
cannot elicit T cell expansion. Figure 4B demonstrates not
only the capability of obtaining robust quantitative data
for T cell activation using our assay system, but also the
high degree of antigen-specificity recorded in the
experiment.
Discussion
We report here the industrialization of membrane protein
microarrays suitable for basic research and drug discovery
applications in numerous aspects of membrane biology,
from multivalent ligand/receptor interactions to live cell
assays. Through robotic handling approaches, it is possi-
ble to construct high density arrays of supported lipid
bilayers containing unlimited unique combinations of
membrane components. The experiments illustrated in
Figure 2 and Figure 3 underscore the physiological integ-
rity of our membranes as determined by their in vivo-like
fluidity, as well as the ability to array these membranes at
high density without causing mixing of contents among
corrals. The high quality of the arrayed membranes is
extremely reproducible between corrals and among differ-
ent chips. Further, the precision of the arraying equipment
facilitates deposition of unique membrane compositions
in specific corrals of a membrane array. The physiological
fluidity of each discretely-arrayed bilayer is truly what ena-
bles the study of membrane processes, which often
require the dynamic lateral motion of proteins and lipids.
In order to validate our system for studying membrane
biology, we first examined the interaction between CTB
and GM1, a multivalent binding event likely to require flu-
idity of the bilayer for proper complex formation. As illus-
trated in Figure 3, a vast amount of high content data can
be obtained rapidly (within minutes) for the CTB/GM1
system, or nearly any other ligand/receptor system, given
the ease with which concentrations of ligand and receptor
can be varied and analyzed. This advantage would be
extremely beneficial for investigating the pharmacody-
namics of essentially any ligand against membrane com-
ponents. Indeed, the experiment depicted in Figure 3 was
performed rapidly and only required 8 wells of a 96-well
microtitre plate. Given the physiological level of fluidity
in our supported membrane arrays, it is possible to study
ligand/receptor interactions in a manner beyond captur-
ing mere binding data. Actual signaling can be examined
using our technology, given that the fluid and dynamic
motion of membrane components is preserved. We chose
the CTB/GM1 interaction precisely for its multivalency, a
property which may require fluidity of the surrounding
lipid membrane environment for proper complex forma-
tion. Indeed, pentavalent CTB is thought to recruit five
GM1molecules in a process that demonstrates positive
cooperativity among the components [16,17]. Hence, the
characteristic fluidity of our lipid bilayers is what permits
the study of CTB/GM1 and likely numerous other mem-
brane receptors on an almost in vivo-like level. While the
CTB/GM1 system is instructive for studying multivalent
ligand/receptor interactions in the context of fluid mem-
branes, we wanted to validate our technology for studying
various other types of membrane components. Our ability
to display bacterial LPS could facilitate academic studies
in the area of host/pathogen interaction, as well as lead to
the identification of novel therapeutics to treat life-threat-
ening septic shock. While the polymyxin family of
amphiphilic antibiotics target LPS, there is a continuing
push to develop more efficacious anti-endotoxin mole-
cules to treat sepsis [22]. For example, candidate antibody
or small molecule therapeutics for septic shock could be
identified from studying the interaction of immune sys-
tem cells with membrane surfaces displaying LPS. In order
to validate our technology for live cell-based assays, we
have examined the activation of intact T cells on mem-
brane arrays displaying molecules critical for adhesion
and antigen-presentation. As in the case of the CTB/GM1
interaction, we chose a cell-cell association (in this case T
cells and antigen-presenting cells) which would highlight
the power of our fluid lipid bilayer technology to faith-
fully mimic in vivo membrane environments. The
adhesion of T cells to the supported membranes (Figure
4A) models the first mechanistically-distinct stage of T cell
activation, which happens to be an important point for
therapeutic intervention in a number of immunological
disorders. Indeed, Raptiva, the recently-approved anti-
body therapeutic for psoriasis, directly targets the ICAM-
1/LFA-1-mediated T cell adhesion process [23]. In addi-
tion to cell adhesion, our ability to measure full T cell acti-
vation in both qualitative and quantitative formats
underscores our ability to capture actual signal transduc-
tion events occurring on our fluid lipid bilayers, which
enable the dynamic reorganization of surface receptors so
crucial for this process. While T cell adhesion and partial
activation has been demonstrated on arrays consisting
solely of MHC deposited on a glass surface without mem-
branes or other molecules present, it is possible that this
technology fails to capture important nuances of the acti-
vation pathway which may be critical in identifying novelBMC Biotechnology 2005, 5:18 http://www.biomedcentral.com/1472-6750/5/18
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membrane components capable of modulating these
processes [24]. In addition, drugs targeting the T cell acti-
vation process may have subtle effects which can be dis-
tinguished only through qualitative observation of the
dynamic "immunological synapse." Studying T cell activa-
tion in array format could be quite useful in identifying
the roles of various T cell or antigen-presenting cell mem-
brane proteins in this process. Specifically, these proteins
could be arrayed in the presence of antigen-presentation
machinery in order to assess their precise roles in the dis-
tinct stages of T cell activation, including T cell adhesion,
T cell stopping, and synapse formation. In essence, activa-
tion of live T cells on our supported membranes greatly
facilitates high information-content immunological
assays.
Conclusion
Our membrane protein microarray system extends the
capabilities of DNA and protein arrays. While the latter
have successfully industrialized the analysis of gene and
protein expression, fluid cell membrane arrays represent
the industrialization of membrane biology. Given that the
vast majority of pharmaceuticals, including most of the
recent protein- and antibody-based therapeutics, target
membrane components, this system has the capability to
advance the drug discovery process. Moreover, the tech-
nology is also useful for academic research applications,
which will undoubtedly form the basis of many future
therapeutic opportunities. The combination of physiolog-
ical in vivo-like qualities of our membranes with robotic
arraying has created a powerful system for studying mem-
brane biology in a high throughput fashion.
Methods
Reagents
Egg phosphatidylcholine (egg-PC) and 1-Palmitoyl-2-
[12-[(7-nitro-2-1,3-benzoxadiazol-4-
yl)amino]dodecanoyl]-sn-Glycero-3- [Phospho-rac-(1-
glycerol)] (ammonium salt) (16:0-12:0 NBD-PG) were
obtained from Avanti Polar Lipids. N-Texas Red sulfonyl-
1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine
(triethylammonium salt) (Texas Red DHPE) and CTB
(recombinant) Alexa Fluor® 594 conjugate (labeled CTB)
were obtained from Molecular Probes (presently Invitro-
gen). Unlabeled CTB was purchased from Sigma Chemi-
cal Co.
Fabrication of supported membrane arrays
Micropatterned substrates were fabricated on glass wafers,
micropatterned with chrome barriers following a "pira-
nha clean" (3:1 mixture of sulfuric acid and 30% solution
of hydrogen peroxide). Array surfaces were cleaned by
soaking for 20 minutes in freshly prepared piranha solu-
tion. Subsequently, the surfaces were rinsed under deion-
ized water. The small unilamellar vesicles (SUVs) were
prepared by standard extrusion methods. Briefly, lipids
were mixed in the desired concentrations in chloroform,
followed by evaporation of the chloroform in a round
bottom flask using a rotary evaporator (Buchi, Rotovap
R200). The lipids were resuspended in distilled water and
stored overnight. Following hydration overnight at 4°C,
they were passed 21 times through an Avanti extruder
containing a membrane with 100-nm pores. The extruded
vesicles were stored at 4°C until use within several weeks.
Planar supported bilayers were formed by fusion of SUVs
onto the piranha-cleaned surfaces. Prior to supported
membrane deposition, spreading solutions were prepared
by mixing the SUV suspensions in equal ratios with phos-
phate-buffered saline (PBS). The fabrication of lipid
microarrays was carried out using a microarrayer (Carte-
sian technologies model MycroSys™ SQ series) equipped
with software (AxSys™ software) for programmable aspi-
ration and dispensing. Due to the very small drop size
(nanoliters), the microarrayer was enclosed in a humidi-
fied chamber (~98% humidity) at room temperature to
avoid evaporation. In order to prevent contamination
from carryover between different lipid solutions, an auto-
matic wash cycle was incorporated into every arraying
program that consisted of consecutive washes in deion-
ized water and dry cleaning before each sample aspira-
tion. Following the arraying step, the arrayed elements
were submerged in deionized water. They were then
washed 3 times with PBS, followed by incubation with
CTB in PBS on a rocker (set at 2.75) for one hour at room
temperature. Subsequently, they were washed 6 times
with PBS on the rocker (set at 2.75) with 5-minute washes
for the last three.
Reconstitution of LPS into SUVs
The pathogenic moiety of LPS (lipid A) was isolated from
R595 LPS (LPS from deep rough mutant of Salmonella
enterica Minnesota strain R595) by sodium acetate buffer
treatment (0.1 M, pH 4.4, 100°C for 1 hour) and was dis-
solved in a 65:25:4 ratio mixture of chloroform:metha-
nol:deionized water. Multilamellar vesicle formation was
performed using standard methods. Briefly, the solvent
was evaporated from the lipid mixture using a rotary evap-
orator (Buchi Rotary Evaporators, C Assembly). The
remaining lipid cake was hydrated overnight at 4°C to
form multilamellar vesicles. Multilamellar vesicles were
sonicated in order to increase the incorporation of LPS
into unilamellar vesicles, followed by extrusion to isolate
the SUV population. The monoclonal IgG2b anti-lipid A
antibody (A6) was prepared as previously described [25].
The goat anti-mouse IgG (H&L) antibody conjugated to
Cy2 was purchased from Jackson ImmunoResearch Labo-
ratories. Standard immunofluorescence protocols as rec-
ommended by Jackson Immuno were followed.BMC Biotechnology 2005, 5:18 http://www.biomedcentral.com/1472-6750/5/18
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Generation and display of ICAM-1 and I-Ek
cDNAs encoding the extracellular domains (excluding sig-
nal sequences) of human ICAM-1 and murine I-Ek (alpha
and beta chains) were amplified from ESTs (Invitrogen)
and subcloned into pcDNA3.1 (Invitrogen) modified to
encode a fused in-frame signal sequence and His6
sequence in tandem at the N-terminus and a GPI-specify-
ing sequence at the C-terminus (pYBS101) as HindIII-XbaI
fragments with enterkinase-encoding cleavage sites
(DDDDK) at their N-termini to generate proteins having
a C-terminal GPI anchor. CHO cells were transfected with
expression plasmids using calcium phosphate transfec-
tion (Promega) or SuperFect (Qiagen) following manu-
facturers' recommendations. 48 hours after transfection,
cells were split at 1:5, 1:10 and 1:20 into growth media
containing 500 µg/ml of G418 (Invitrogen) for generation
of stable lines expressing human ICAM-1 or murine I-Ek.
Polyclonal stable cell lines were maintained and passaged
in G418-containing media for 4 weeks. Expression of
these proteins was confirmed by FACS analysis using PE-
conjugated antibodies (Becton Dickinson). Confluent
CHO cells from 6–8 10-cm dishes were washed 2X with
cold PBS, and were scraped into 600 µL (per dish) of lysis
buffer containing 50 mM Tris-Cl pH 8.0, 150 mM NaCl,
and 1% Triton X-100, and a protease inhibitor cocktail
(Sigma). Harvested cells were solubilized on ice for 30
minutes, followed by microcentrifugation for 15 min at
the highest speed. Ni-NTA agarose (Qiagen) was washed
1X with lysis buffer and added to clarified extracts (50 µL
of beads per 600 uL of cell extract). Cell extracts were incu-
bated with beads for 2 hours with rotation at 4°C. Beads
were washed 4X with buffer containing 50 mM Tris-Cl pH
8.0, 150 mM NaCl, 10 mM imidazole (Sigma), and 1%
Octyl-Glucopyranoside (Calbiochem) plus a protease
inhibitor cocktail (Calbiochem). Bound proteins were
eluted with 600 µL of buffer containing 50 mM Tris-Cl pH
8.0, 150 mM NaCl, 200 mM imidazole, and 1% Octyl-
Glucopyranoside plus a protease inhibitor cocktail for 1
hour at 4°C with rotation. Aliquots of protein extracts
were added to an egg phosphatidylcholine (PC) lipid mix
(1% NBD-PG, 99% egg PC) and dialyzed overnight at
room temperature against PBS, with 3X buffer changes.
While egg PC was used to generate membranes in this
case, these proteins could easily be reconstituted in vesi-
cles with various lipid compositions. To form the sup-
ported lipid membranes, 20 µL of undiluted (or diluted
1:2) protein-lipid mix was deposited onto silicon chips or
cover slips for 3–5 min at room temperature, followed by
5 washes with buffer. Incorporation of protein into the
supported membrane was confirmed by immunofluores-
cence using antibodies to the respective protein. Mem-
branes were stained with 30 µL of PE-conjugated
antibodies (BD Pharmingen) in 5% fetal calf serum (FCS)
for 30 min, and then washed extensively with PBS and
assessed by fluorescence microscopy. Protein densities are
approximately 10,000–20,000 molecules/µm2, as esti-
mated from a proteolipid concentration of 0.6 µg/µL
(50% pure) in a 20-µL drop on a chip surface of 7 mm
diameter. It was assumed that only 1% of the drop con-
tents is retained on the chip surface for membrane
display.
T cell isolation, adhesion, and immunological synapse 
formation
Murine T cells specific for PCC were derived from spleens
harvested from the T cell receptor transgenic mouse
strains B10.Cg-Tg(TcrAND)53Hed/J and B6;SJL-
Tg(TcrAND)53Hed/JCell (The Jackson Laboratory). T cells
were isolated from splenocytes by magnetic bead selec-
tion (Dynal) according to the manufacturer's instructions.
T cell adhesion assays to supported membranes display-
ing either ICAM-1 or I-Ek as GPI-linked proteins were per-
formed as previously described with several modifications
[26]. Briefly, membranes were blocked with 10% fetal
bovine serum (FBS) in PBS for 1 hour at room tempera-
ture, followed by incubation for 10 minutes with RPMI
1640 media (Invitrogen) containing 10% FBS at 37°C.
Approximately 1 × 105 T cells were added to the well for
15 minutes. Following incubation with cells, corrals were
washed for 10–15 minutes in the presence of PBS with 5%
serum. Where appropriate, blocking antibodies were used
at an approximately 1:100 dilution. The approximate
number of cells per membrane corral was determined by
counting under a brightfield microscope (usually 150–
200 cells/corral). Supported lipid bilayers were
subsequently inverted into a dish containing 10% FBS in
PBS for 15–20 minutes to wash unbound cells. The final
cell number was determined by counting under micro-
scope directly or after imaging. In experiments where
monoclonal antibodies against human ICAM-1 or murine
I-Ek (Santa Cruz) were used to block T cell adhesion, sup-
ported membranes were pre-incubated with antibody fol-
lowed by 3 washes with PBS prior to incubation with cells.
"Immunological synapse" formation experiments were
performed as described previously [21]. Imaging was per-
formed on a Nikon Eclipse 300 vertical microscope, and
analysis and quantitation were performed using Adobe
Photoshop.
Imaging of membrane arrays
Imaging of the membrane microarrays was performed on
a Nikon Eclipse 300 vertical microscope using a 4 × objec-
tive. Fluorescence images were taken with the same objec-
tive in fluorescence mode. The supported membranes
were fluorescently labeled with 1 mol % of NBD, Texas
Red-tagged lipids or labeled CTB. Images were recorded
with a digital color camera driven by CoolSnap software.
In cases where it was not possible to image the entire chip
in one field (e.g. a 64 corral chip), the image was recon-
structed in piecemeal fashion. We used Adobe PhotoshopPublish with BioMed Central    and   every 
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software to measure the intensity of each corral and
Microsoft Excel to analyze the data.
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